Turtle Cameron - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (SYRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 15, 2024, Turtle Cameron's relationship to Spyre Therapeutics, Inc. (SYRE) is Director,Officer (Chief Executive Officer), and currently has 746,907 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRE insiders.
Data Source: SEC.
Turtle Cameron - Insider Non-Derivative Transactions at SYRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 16, 2024 | Acquisition -- (Common Stock) | 400 | 9.82 | 746907 |